Internal Medicine, Gastroenterology · Fort Worth, TX
NPI
1992714414
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1325 Pennsylvania Ave Ste 890
Fort Worth, TX, 76104
Phone (817) 250-7230
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
587 services
Medicare patients, 2024
278
Average age 73
Drug cost, 2024
$3.5M
1,218 prescriptions
Company payments, 2025
$32K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tasneem F Ahmed was code 99232 (hospital e&m - subsequent), 110 times for 86 patients. In total Tasneem F Ahmed billed 587 services in 36 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 110 | 86 | $57.39 | $6,312 |
| 99214 Office E&M - Established | Office | 80 | 65 | $90.15 | $7,212 |
| 45380 Lower GI Endoscopy - Other | Facility | 72 | 71 | $95.70 | $6,890 |
| 99222 Hospital E&M - Initial | Facility | 65 | 64 | $100.58 | $6,538 |
| 43239 Upper GI Endoscopy | Facility | 60 | 59 | $81.94 | $4,917 |
| 99204 Office E&M - New | Office | 36 | 36 | $112.88 | $4,064 |
| 45385 Colonoscopy - Lesion Removal | Facility | 30 | 29 | $194.95 | $5,849 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 19 | $91.97 | $1,931 |
| 99215 Office E&M - Established | Office | 17 | 13 | $126.09 | $2,144 |
| 43235 Upper GI Endoscopy | Facility | 17 | 15 | $80.60 | $1,370 |
| 45381 Lower GI Endoscopy - Other | Facility | 14 | 13 | $12.04 | $169 |
By year: 2022 $59K for 651 services; 2023 $57K for 618 services; 2024 $55K for 587 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tasneem F Ahmed prescribed most often to Medicare patients was Pantoprazole Sodium, with 238 prescriptions and refills. In total Tasneem F Ahmed wrote 1,218 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 238 | 426 | 69 | $2,181 |
| Dicyclomine Hcl Generic | 85 | 129 | 39 | $3,052 |
| Stelara Ustekinumab | 77 | 101 | 13 | $2.1M |
| Mesalamine Generic | 68 | 116 | 14 | $29K |
| Famotidine Generic | 62 | 100 | 18 | $1,298 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 62 | 62 | 57 | $894 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 59 | 59 | 54 | $962 |
| Entyvio Vedolizumab | 59 | 73 | Under 11 | $505K |
| Linzess Linaclotide | 40 | 56 | 16 | $30K |
| Omeprazole Generic | 38 | 60 | 12 | $274 |
| Sodium Chloride 0.9 % Sodium Chloride | 30 | 34 | Under 11 | $382 |
| Budesonide Dr Budesonide | 29 | 34 | Under 11 | $1,932 |
| Metronidazole Generic | 26 | 28 | 23 | $499 |
| Prednisone Generic | 24 | 24 | Under 11 | $173 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 24 | 24 | Under 11 | $1,873 |
Brand drugs: 412 claims; generic drugs: 806 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tasneem F Ahmed $32K ($32K in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 45 | $20K |
| Lilly USA, LLC LLY | 9 | $6,178 |
| Celltrion USA Inc. 068270.KS | 6 | $4,994 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $188 |
| Janssen Biotech, Inc. JNJ | 9 | $149 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $101 |
| Pfizer Inc. PFE | 4 | $78.83 |
| Mallinckrodt Hospital Products Inc. | 1 | $28.16 |
| Aimmune Therapeutics, Inc. | 1 | $18.9 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $17.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.